The Sir Ganga Ram Hospital on Tuesday started administering monoclonal antibody cocktail (MAC) to coronavirus patients, the medical facility said in a statement.
The hospital is administering a combination of casirivimab and imdevimab to consenting patients with mild and moderate COVID-19 symptoms at high risk of developing serious illness, it added.
The MRP of one MAC dose for a patient is Rs 59,750, the statement said.
According to the Drug Controller General of India (DCGI), selection of patients will entail that they have Covid positive test report, mild to moderate Covid disease, are in the age group of 12 and above and weighing at least 40 kg, and are at high risk of COVID-19.
Dr DS Rana, Chairman (BOM), Sir Ganga Ram Hospital said, “As per the claims of the company Roche/ Cipla, we hope MAC will be a major factor in the fight against COVID-19 to prevent disease from progressing to further severity.”
(Cover: Representational / Credit – Getty Images)
Delhi Police raided a late-night illegal bar in Samaypur Badli, detaining 25 people and seizing…
A rear-end crash near Delhi Haat triggered a blaze that gutted both vehicles, though no…
Court grants probe agency more time as NIA pursues wider links in Red Fort blast…
Featuring works in thread, fabric, performance and digital media, Ski(e)n examines the body as a…
Govt report shows gains in maternal health, with better care access and fewer anaemia cases…
Delhi driver murdered after petty dispute; birthday celebration turns violent, say police
